Converge Bio: Series AAI platform for accelerated drug discovery and developmentOct 4, 2026RoundOSConverge BioCompany profile and funding historySourcesprnewswire.comMore in AIDe¹ · StrategicOwner · Series DMetriport · Series AAISeries A · AIBiotechUnited StatesNorth AmericaSeries A